INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH
1.5K subscribers
About INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH
An International Journal published monthly
Similar Channels
Social Science Simplified
UPSC ONLINE GK CURRENT AFFAIR BPSC SSC RAILWAY LUCENT NCERT HISTORY MATH SCIENCE ENGLISH MOTIVATION
Battery Directory & Year Book (since 1985)
The world of science
UDASIKRUPA INTERNATIONAL
#Guareña
Informatic International
Research & Education
INNOVISION - Domestic & International - Jobs & Placements
Kurzy pro radost
Ornitho-Genetics VZW - Dirk Van den Abeele
SANGIA Publishing
The American Center of Research (ACOR)
LIS Links: Library and Information Science Links
pedaliAMOconSarah
Swipe to see more
Posts
*Last Day to register - Closes Today at 5 PM IST!* *90th SPSR Webinar* on ‘Integrative Approaches in Dementia: Synergizing Traditional Medicine with Modern Science', hosted by the Society of Pharmaceutical Sciences and Research (SPSR), scheduled for Sunday, 25th May 2025, beginning at 11:00 AM IST. *Esteemed Speaker : Dr. Rakesh Barik*, Asst. Professor, GITAM School of Pharmacy, GITAM Deemed to be University, Hyderabad, Telangana, India. Watch Live on SPSR YouTube Channel.: https://youtube.com/live/QqISDv5iSUg?feature=share Register now (Closes at 5 PM IST today!): https://forms.gle/bEDRiAtPhwqKwvRn8 Become a Member of SPSR - Elevate Your Professional Journey! For more details visit https://spsrpharma.org/become-a-member
Break the stigma, embrace understanding! World Schizophrenia Awareness Day is observed on May 24th each year to raise awareness about schizophrenia, combat stigma, and promote better mental health care. Recent advancements are shaping a new era in schizophrenia care, offering hope for better treatment outcomes. ✅ 1. New Treatment Approaches 🧠 Transcranial Magnetic Stimulation (TMS) – Uses magnetic fields to stimulate nerve cells in the brain, offering a non-invasive treatment option. 🧠 Deep Brain Stimulation (DBS) – Involves implanting electrodes in the brain to regulate abnormal impulses, showing promise for severe cases. 🧠 Cobenfy (Xanomeline-Trospium Chloride) – A newly approved medication with a novel mechanism of action, marking a breakthrough in schizophrenia treatment ✅ 2. Neuroscience & Genetic Discoveries 🧠 Dopamine & Glutamate Research – Studies continue to refine our understanding of neurotransmitter imbalances in schizophrenia, leading to more targeted therapies. 🧠 IDO2 Protein & Brain Chemistry – Research suggests that the IDO2 protein plays a role in schizophrenia and related disorders, potentially opening new treatment pathways. ✅ 3. Emerging Therapies & Future Directions 🧠 Long-Acting Injectable Medications – New formulations improve medication adherence and symptom management. 🧠 Synapse Regeneration & Genetic Models – Scientists are exploring ways to repair brain connections and develop personalized treatments. Become a part of our dynamic LinkedIn community to stay updated on the latest trends in publishing, research, and pharmaceutical webinars. Gain access to exclusive insights and opportunities that can enhance your career. Follow us today and embark on the SPSR journey with us! https://www.linkedin.com/company/spsr2010
https://youtube.com/live/QqISDv5iSUg?feature=share Live session going on..
May 2025 FDA DRUG APPROVAL: Emrelis (telisotuzumab vedotin) 🫁 Mechanism of Action: Emrelis is a c-Met-directed antibody-drug conjugate (ADC) that targets cancer cells with high c-Met protein overexpression and delivers a cytotoxic payload to destroy them. 🫁 Indication: Approved for locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) with high c-Met protein overexpression (≥50% tumor cells with strong staining). 🫁 Side Effects: Common adverse reactions include peripheral neuropathy, fatigue, decreased appetite, and peripheral edema. Become a part of our dynamic LinkedIn community to stay updated on the latest trends in publishing, research, and pharmaceutical webinars. Gain access to exclusive insights and opportunities that can enhance your career. Follow us today and embark on the SPSR journey with us! https://www.linkedin.com/company/spsr2010
*90th SPSR Webinar* on ‘Integrative Approaches in Dementia: Synergizing Traditional Medicine with Modern Science', hosted by the Society of Pharmaceutical Sciences and Research (SPSR), scheduled for Sunday, 25th May 2025, beginning at 11:00 AM IST. *Our esteemed speaker for this event is Dr. Rakesh Barik*, Asst. Professor, GITAM School of Pharmacy, GITAM Deemed to be University, Hyderabad, Telangana, India. The webinar will be streamed live through the SPSR YouTu be Channel. You can use this link to visit the SPSR YouTube Channel: https://youtube.com/live/QqISDv5iSUg?feature=share To register for the webinar, please click on the following link to reach the registration form: https://forms.gle/bEDRiAtPhwqKwvRn8 Last date of registration – 24th May 2025, 5 PM IST. Become a Member of SPSR - Elevate Your Professional Journey! For more details visit https://spsrpharma.org/become-a-member
*Join us today at 11 AM IST!* *90th SPSR Webinar* on ‘Integrative Approaches in Dementia: Synergizing Traditional Medicine with Modern Science', hosted by the Society of Pharmaceutical Sciences and Research (SPSR). *Esteemed Speaker : Dr. Rakesh Barik*, Asst. Professor, GITAM School of Pharmacy, GITAM Deemed to be University, Hyderabad, Telangana, India. Watch Live on SPSR YouTube Channel.: https://youtube.com/live/QqISDv5iSUg?feature=share Webinar Feedback link: https://forms.gle/z5axM31q2HxNdsdPA Note - Make sure to fill out the feedback form during the live session to claim your participant certificate! Become a Member of SPSR - Elevate Your Professional Journey! For more details visit https://spsrpharma.org/become-a-member
THE ROLE OF HERBAL MEDICINE IN IMMUNE SYSTEM ENHANCEMENT: A TRADITIONAL AND MODERN PERSPECTIVE Herbal medicine has played a crucial role in traditional healing systems around the globe, especially in boosting immune function. This review delves into the historical importance of herbal remedies for immune modulation within various traditional medical frameworks, such as Ayurveda, Traditional Chinese Medicine (TCM), and indigenous healing practices. Dive into this article here 🔗https://ijpjournal.com/bft-article/exploring-natural-sources-of-antioxidants-and-their-potential-uses-in-health-and-industry🔗. Whether you're a student, researcher, caregiver, or simply curious, this comprehensive overview will deepen your understanding and inspire new perspectives. Become a member of our dynamic LinkedIn community to stay informed about the latest trends in publishing, research, and pharmaceutical webinars. Access exclusive insights and opportunities that can elevate your career. Follow us today and start your journey with SPSR! https://www.linkedin.com/company/spsr2010
May 2025 FDA DRUG APPROVAL: Nuvaxovid – Strengthening Immunity, Protecting Lives! It is a protein-based, non-MRNA vaccine for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). ✅ Indication: Approved for individuals 65 years and older and those 12-64 years with underlying conditions. ✅ Technology: Uses recombinant nanoparticle technology to mimic the spike protein of SARS-CoV-2. ✅ Efficacy: Proven safe and effective in preventing COVID-19. 🔴 Common Side Effects of Nuvaxovid 🔴 Like most vaccines, Nuvaxovid may cause mild to moderate side effects, which typically resolve within a few days. Here are some commonly reported reactions: 🔺 Injection Site Reactions: Pain, tenderness, redness, or swelling at the injection site. 🔺 General Symptoms: Fatigue, headache, muscle pain, and joint pain. 🔺 Flu-like Symptoms: Fever, chills, nausea, and vomiting. 🔺 Less Common Effects: Swollen lymph nodes, fainting, and inflammation-related conditions (e.g., myocarditis or pericarditis). Most side effects are temporary and indicate that the immune system is responding to the vaccine. However, if symptoms persist or worsen, consulting a healthcare professional is advised. Nuvaxovid offers a more traditional vaccine approach, making it an appealing option for those hesitant about newer mRNA technology. Become a part of our dynamic LinkedIn community to stay updated on the latest trends in publishing, research, and pharmaceutical webinars. Gain access to exclusive insights and opportunities that can enhance your career. Follow us today and embark on the SPSR journey with us! https://www.linkedin.com/company/spsr2010
Alzheimer’s disease (AD) is the most prevalent form of dementia, affecting millions worldwide. It is a progressive, irreversible #neurodegenerative disorder that significantly impairs memory, thinking, and behavior, posing a major public health challenge. Ongoing research continues to uncover its complex pathology and offers hope for better diagnosis and treatment. Current studies adopt a holistic approach to better understand disease mechanisms and develop more effective, personalized treatments. Dive into this article here 🔗 https://ijpsr.com/bft-article/a-holistic-perspective-on-psychogenic-malady-alzheimer 🔗 to check the causes, genetic factors, and cutting-edge research shaping the future of diagnosis and treatment. Whether you're a student, researcher, caregiver, or simply curious, this comprehensive overview will deepen your understanding and inspire new perspectives. Read on to uncover how science is unraveling the mysteries of #Alzheimer's—and what hope lies ahead. Become a part of our dynamic LinkedIn community to stay updated on the latest trends in publishing, research, and pharmaceutical webinars. Gain access to exclusive insights and opportunities that can enhance your career. Follow us today and embark on the SPSR journey with us! https://www.linkedin.com/company/spsr2010
Avmapki Fakzynja Co-Pack is a combination therapy comprising avutometinib, a MEK inhibitor, and defactinib, a FAK inhibitor, provided in a co-packaged format for the treatment of specific cancers. ⭕ Indication: ➡️ Primarily indicated for the treatment of patients with low-grade serous ovarian cancer (LGSOC), particularly those with RAS pathway mutations who have received prior systemic therapy. It may be used in other investigational settings as well. ⭕ Mechanism of Action: ➡️ Avutometinib inhibits MEK1/2, blocking the MAPK pathway which is often hyperactivated in cancers with RAS/RAF mutations. Defactinib targets focal adhesion kinase (FAK), a protein involved in tumor cell survival, proliferation, and resistance to therapy. ⭕ Therapeutic Benefit: ➡️ The combination aims to overcome resistance mechanisms in RAS-mutant tumors by dual inhibition of MEK and FAK pathways, potentially improving clinical outcomes in patients with hard-to-treat cancers. Become a part of our dynamic LinkedIn community to stay updated on the latest trends in publishing, research, and pharmaceutical webinars. Gain access to exclusive insights and opportunities that can enhance your career. Follow us today and embark on the SPSR journey with us! https://www.linkedin.com/company/spsr2010
